Avidity Biosciences Income from Continuous Operations 2019-2024 | RNA
Avidity Biosciences income from continuous operations for the twelve months ending September 30, 2024 was $-0.280B, a 38.69% increase year-over-year.
- Avidity Biosciences annual income from continuous operations for 2023 was $-0.212B, a 21.97% increase from 2022.
- Avidity Biosciences annual income from continuous operations for 2022 was $-0.174B, a 47.44% increase from 2021.
- Avidity Biosciences annual income from continuous operations for 2021 was $-0.118B, a 166.06% increase from 2020.